AAAAAA
Results:
1-14
|
Results: 14
Authors:
Drake, WM
McClung, M
Njeh, CF
Genant, HK
Rosen, C
Watts, N
Kendler, DL
Citation: Wm. Drake et al., Multisite bone ultrasound measurement on North American female reference population, J CLIN DENS, 4(3), 2001, pp. 239-248
Authors:
Drake, WM
Parkinson, C
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Clinical use a of growth hormone receptor antagonist in the treatment of acromegaly, TRENDS ENDO, 12(9), 2001, pp. 408-413
Authors:
Drake, WM
Parkinson, C
Akker, SA
Monson, JP
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Successful treatment of resistant acromegaly with a growth hormone receptor antagonist, EUR J ENDOC, 145(4), 2001, pp. 451-456
Authors:
Njeh, CF
Saeed, I
Grigorian, M
Kendler, DL
Fan, B
Shepherd, J
McClung, M
Drake, WM
Genant, HK
Citation: Cf. Njeh et al., Assessment of bone status using speed of sound at multiple anatomical sites, ULTRASOUN M, 27(10), 2001, pp. 1337-1345
Authors:
Drake, WM
Rodriguez-Arnao, J
Weaver, JU
James, IT
Coyte, D
Spector, TD
Besser, GM
Monson, JP
Citation: Wm. Drake et al., The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitaryadults: a 5-year study, CLIN ENDOCR, 54(4), 2001, pp. 525-532
Authors:
Drake, WM
Howell, SJ
Monson, JP
Shalet, SM
Citation: Wm. Drake et al., Optimizing GH therapy in adults and children, ENDOCR REV, 22(4), 2001, pp. 425-450
Authors:
Drake, WM
Kendler, DL
Brown, JP
Citation: Wm. Drake et al., Consensus statement on the modern therapy of Paget's disease of bone from a western osteoporosis alliance symposium, CLIN THER, 23(4), 2001, pp. 620-626
Authors:
Trainer, PJ
Drake, WM
Perry, LA
Taylor, NF
Besser, GM
Monson, JP
Citation: Pj. Trainer et al., Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly, J CLIN END, 86(7), 2001, pp. 2989-2992
Authors:
Frajese, G
Drake, WM
Loureiro, RA
Evanson, J
Coyte, D
Wood, DF
Grossman, AB
Besser, GM
Monson, JP
Citation: G. Frajese et al., Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy, J CLIN END, 86(11), 2001, pp. 5172-5175
Authors:
Trainer, PJ
Drake, WM
Katznelson, L
Freda, PU
Herman-Bonert, V
van der Lely, AJ
Dimaraki, EV
Stewart, PM
Friend, KE
Vance, ML
Besser, GM
Scarlett, JA
Thorner, MO
Parkinson, C
Klibanski, A
Powell, JS
Barkan, AL
Sheppard, MC
Maldonado, M
Rose, DR
Clemmons, DR
Johannson, G
Bengtsson, BA
Stavrou, S
Kleinberg, DL
Cook, DM
Phillips, LS
Bidlingmaier, M
Strasburger, CJ
Hackett, S
Zib, K
Bennett, WF
Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
Authors:
Drake, WM
Lowe, SR
Mirtella, A
Bartlett, TJ
Clark, AJL
Citation: Wm. Drake et al., Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells, J ENDOCR, 165(1), 2000, pp. 133-138
Authors:
Drake, WM
Ajayi, A
Lowe, SR
Mirtella, A
Bartlett, TJ
Clark, AJL
Citation: Wm. Drake et al., Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: Implications for the RAMP hypothesis, ENDOCRINOL, 140(1), 1999, pp. 533-537
Authors:
Drake, WM
Monson, JP
Citation: Wm. Drake et Jp. Monson, Individual susceptibility and GH dosing regimen in adults, CHALLENGES IN GROWTH HORMONE THERAPY, 1999, pp. 143-159
Authors:
Drake, WM
Miraki, F
Siddiqi, A
Yateman, M
Barnes, NC
Camacho-Hubner, C
Monson, JP
Citation: Wm. Drake et al., Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia, EUR J ENDOC, 139(5), 1998, pp. 532-536
Risultati:
1-14
|